Skip to content

Instantly share code, notes, and snippets.

@haknick
Created May 24, 2017 16:37
Show Gist options
  • Star 0 You must be signed in to star a gist
  • Fork 0 You must be signed in to fork a gist
  • Save haknick/bedda20d89c9e922def11ae10fb11fab to your computer and use it in GitHub Desktop.
Save haknick/bedda20d89c9e922def11ae10fb11fab to your computer and use it in GitHub Desktop.
<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/ramda/0.21.0/ramda.min.js"></script>
<script type="text/javascript" src="https://code.jquery.com/jquery-3.2.1.min.js"></script>
<body class="clinical-trials">
<div class="monotherapy"></div>
</body>
<script>
/*
t can be any of 1 to 5000
*/
var data = {
triggerPoints: [["therapy-tablet",1703],["loading-dose",2227],["oral-and-iv-solution",3014],["special-populations",4725]],
seo: [
{
'id': 'clinical-trials',
'title': 'Clinical Trials | VIMPAT\u00ae (lacosamide) CV',
'desc': 'Learn more about VIMPAT® (lacosamide) CV. See clinical data for adjunctive therapy and monotherapy pivotal trials.',
'prev': '',
'next': '/clinical-trials/adjunctive-therapy',
'url': '/clinical-trials',
'root': true
},
{
'id': 'adjunctive-therapy',
'title': 'Adjunctive Clinical Data | VIMPAT\u00ae (lacosamide) CV',
'desc': 'See clinical data from adjunctive pivotal trials for VIMPAT® (lacosamide) CV, indicated for patients with partial-onset (focal) seizures.',
'prev': '/clinical-trials',
'next': '/clinical-trials/monotherapy',
'url': '/clinical-trials/adjunctive-therapy',
'root': false
},
{
'id': 'monotherapy',
'title': 'Monotherapy Clinical Data | VIMPAT\u00ae (lacosamide) CV',
'desc': 'See clinical data from monotherapy pivotal trials for VIMPAT\u00ae (lacosamide) CV, indicated in patients with partial-onset (focal) seizures.',
'prev': '/clinical-trials/adjunctive-therapy',
'next': '/clinical-trials/loading-dose-trial-data',
'url': '/clinical-trials/monotherapy',
'root': false
},
{
'id': 'loading-dose-trial-data',
'title': 'Loading Dose Trial Data | VIMPAT\u00ae (lacosamide) CV',
'desc': 'Learn about the 200 mg Loading Dose Trial Data for VIMPAT\u00ae (lacosamide) CV, indicated in patients 17 years and older with partial-onset (focal) seizures.',
'prev': '/clinical-trials/monotherapy',
'next':'',
'url': '/clinical-trials/loading-dose-trial-data',
'root': false
},
{
'id': 'dosing-and-formulations',
'title': 'Dosing and Formulations | VIMPAT\u00ae (lacosamide) CV',
'desc': 'Learn about VIMPAT\u00ae (lacosamide) CV dosing and 1:1 conversion between formulations — from tablets to oral solution to intravenous (IV) solution.',
'prev': '/dosing-and-formulations/loading-dose',
'next': '/dosing-and-formulations/therapy-tablet',
'url': '/dosing-and-formulations',
'root': true
},
{
'id': 'therapy-tablet',
'title': 'Tablet Therapy | VIMPAT\u00ae (lacosamide) CV',
'desc': 'Adjunctive Therapy tablet dosing for VIMPAT\u00ae (lacosamide) CV. A therapeutic dose may be achieved after one week. Learn more about formulations and dosing.',
'prev': '/dosing-and-formulations',
'next': '/dosing-and-formulations/loading-dose',
'url': '/dosing-and-formulations/therapy-tablet',
'root': false
},
{
'id': 'loading-dose',
'title': 'Loading Dose Administration| VIMPAT\u00ae (lacosamide) CV',
'desc': 'Learn about the 200 mg Loading Dose for VIMPAT\u00ae (lacosamide) CV, indicated in patients 17 years and older with partial-onset (focal) seizures.',
'prev': '/dosing-and-formulations/therapy-tablet',
'next': '/dosing-and-formulations/oral-and-iv-solution',
'url': '/dosing-and-formulations/loading-dose',
'root': false
},
{
'id': 'oral-and-iv-solution',
'title': 'Intravenous (IV) Injection and Oral Solution | VIMPAT\u00ae (lacosamide) CV',
'desc': 'IV Injection and Oral Solution for VIMPAT\u00ae (lacosamide) CV may be an option when patients cannot swallow tablets. Learn more about formulations and dosing.',
'prev': '/dosing-and-formulations/therapy-tablet',
'next': '',
'url': '/dosing-and-formulations/oral-and-iv-solution',
'root': false
},
{
'id': 'home',
'title': 'Treating Patients with Partial-Onset Seizures | VIMPAT\u00ae (lacosamide) CV',
'desc': 'Learn about VIMPAT® (lacosamide) CV. More than 7 years of real-world experience, flexible dosing, multiple formulations, and patient savings.',
'prev': '',
'next': '/important-safety information',
'url': '/',
'root': true
},
{
'id': 'important-safety-information',
'title': 'HCP Important Safety Information | VIMPAT\u00ae (lacosamide) CV',
'desc': 'See Important Safety Information for VIMPAT\u00ae (lacosamide) CV, and learn more about VIMPAT formulations and dosing for healthcare professionals.',
'prev': '/',
'next': '',
'url': '/important-safety-information',
'root': false
},
{
'id': 'safety',
'title': 'HCP Important Safety Information | VIMPAT\u00ae (lacosamide) CV',
'desc': 'See Important Safety Information for VIMPAT\u00ae (lacosamide) CV, and learn more about VIMPAT formulations and dosing for healthcare professionals.',
'prev': '/',
'next': '',
'url': '/important-safety-information',
'root': false
},
{
'id': 'important-safety-information',
'title': 'HCP Important Safety Information | VIMPAT\u00ae (lacosamide) CV',
'desc': 'See Important Safety Information for VIMPAT\u00ae (lacosamide) CV, and learn more about VIMPAT formulations and dosing for healthcare professionals.',
'prev': '/',
'next': '',
'url': '/important-safety-information',
'root': false
}
]
};
const headerOffset = 0;//114;
var getSEOByPosition = function(scrollTop, headerOffset) {
//--------------------
onsole.log('LENGTH', sections.length);
/* for (var i=0; i<sections.length; i++) {
// if position is above or below nav sections then set the activeSection to null
if (t <= sections[0][1] - headerOffset ) {
for(var j=0; j<seo.length; j++) {
if($('body').hasClass('page-'+seo[j].id)) {
activeSection = seo[j];
break;
}
}
} else if (t >= sections[i][1] - headerOffset) {
for(var k=0; k<seo.length; k++) {
if( seo[k].id === sections[i][0] ) {
activeSection = seo[k];
break;
}
}
} else {
break;
}
} */
}
var a = getSEOByPosition(1704,headerOffset);
console.log(a);
</script>
Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment